Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Dec;14(12):843-56.
doi: 10.1038/nrd4685. Epub 2015 Nov 16.

Clinical experiences with systemically administered siRNA-based therapeutics in cancer

Jonathan E Zuckerman  1 , Mark E Davis  2
Affiliations
Review

Clinical experiences with systemically administered siRNA-based therapeutics in cancer

Jonathan E Zuckerman et al. Nat Rev Drug Discov. 2015 Dec.

Abstract

Small interfering RNA (siRNA)-based therapies are emerging as a promising new anticancer approach, and a small number of Phase I clinical trials involving patients with solid tumours have now been completed. Encouraging results from these pioneering clinical studies show that these new therapeutics can successfully and safely inhibit targeted gene products in patients with cancer, and have taught us important lessons regarding appropriate dosages and schedules. In this Review, we critically assess these Phase I studies and discuss their implications for future clinical trial design. Key challenges and future directions in the development of siRNA-containing anticancer therapeutics are also considered.

PubMed Disclaimer

References

    1. N Engl J Med. 2013 Aug 29;369(9):819-29 - PubMed
    1. Nat Rev Drug Discov. 2007 Jun;6(6):443-53 - PubMed
    1. J Clin Oncol. 2014 Dec 20;32(36):4141-8 - PubMed
    1. Nat Rev Drug Discov. 2008 Sep;7(9):771-82 - PubMed
    1. Mol Ther. 2012 Mar;20(3):483-512 - PubMed

Substances

LinkOut - more resources